Matches in Wikidata for { <http://www.wikidata.org/entity/Q83301615> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q83301615 description "artículu científicu espublizáu en febreru de 2009" @default.
- Q83301615 description "im Februar 2009 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83301615 description "scientific article published on 04 February 2009" @default.
- Q83301615 description "wetenschappelijk artikel" @default.
- Q83301615 description "наукова стаття, опублікована в лютому 2009" @default.
- Q83301615 name "A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1" @default.
- Q83301615 name "A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1" @default.
- Q83301615 type Item @default.
- Q83301615 label "A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1" @default.
- Q83301615 label "A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1" @default.
- Q83301615 prefLabel "A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1" @default.
- Q83301615 prefLabel "A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1" @default.
- Q83301615 P1433 Q83301615-4E1B95E7-CDD8-42E3-9A8D-3A6B5D58B019 @default.
- Q83301615 P1476 Q83301615-0755C440-151F-408C-958D-4A0D0FC2B465 @default.
- Q83301615 P2093 Q83301615-3414AEAB-E080-4BA4-B1E8-EE3607426D7D @default.
- Q83301615 P2093 Q83301615-39BD2C3E-94FE-435A-B107-26A17478CD8C @default.
- Q83301615 P2093 Q83301615-460A7C83-F2F3-4A0F-AD3E-46B46C1B3B3B @default.
- Q83301615 P2093 Q83301615-5FEC7F3E-D81B-4E97-9568-A347FA5AEB39 @default.
- Q83301615 P2093 Q83301615-661AD2EF-1B79-4C76-8D66-F0676942179E @default.
- Q83301615 P2093 Q83301615-83ADDB6C-2FC4-48B2-8CDB-5B1004ACBA3C @default.
- Q83301615 P2093 Q83301615-90346940-C6D1-4C64-9B3A-4C4F525DFA4C @default.
- Q83301615 P2093 Q83301615-D70D9EBB-6DD0-44DA-A615-E39B74379191 @default.
- Q83301615 P2093 Q83301615-FC0CE68F-79BE-4079-8D87-2FFD2F616910 @default.
- Q83301615 P2283 Q83301615-F2F90452-2B67-4332-B6BF-6F7539721F22 @default.
- Q83301615 P2860 Q83301615-1A89DDBA-F1FE-4907-86D0-B5024BDC323D @default.
- Q83301615 P2860 Q83301615-4301788F-0C21-4866-9D90-19E8C4E8B2E9 @default.
- Q83301615 P2860 Q83301615-63C2B05F-BAF9-4590-A0D8-5213BAE39D48 @default.
- Q83301615 P2860 Q83301615-6AD7297E-0762-4C37-8C58-FCB0573FB953 @default.
- Q83301615 P2860 Q83301615-7FFDD4C9-E82F-4702-8036-A0B0F2D4D0E3 @default.
- Q83301615 P2860 Q83301615-8861D798-2E53-481D-8611-C5666A3ACC74 @default.
- Q83301615 P2860 Q83301615-89D983EC-0E15-432E-93D0-B07C7391C2DA @default.
- Q83301615 P2860 Q83301615-8F7AF053-DE08-4437-B3A5-FAC1FFD6DC85 @default.
- Q83301615 P2860 Q83301615-A0857544-F081-454D-9F9C-5B8D00CC1B01 @default.
- Q83301615 P2860 Q83301615-BD808E06-44A5-47E3-99B7-E772B240F0AE @default.
- Q83301615 P2860 Q83301615-E1DDD1B2-9266-4942-A42C-8D9DFCD44C7F @default.
- Q83301615 P2860 Q83301615-EA1AF0B2-5D56-44DF-8316-45B47C043F0B @default.
- Q83301615 P2860 Q83301615-F24EDA1E-DC2E-4B31-A909-75DC7C681B86 @default.
- Q83301615 P304 Q83301615-2E2896E2-F5F8-48DC-B503-F23AFD4CED41 @default.
- Q83301615 P31 Q83301615-E9BB05AF-CCBD-4B89-AFF5-83D18BF60F02 @default.
- Q83301615 P356 Q83301615-079C4399-11BE-4ACC-B1AC-9BFA5ABB6AE3 @default.
- Q83301615 P433 Q83301615-E25EED15-A241-4C81-A338-AE57BF52062C @default.
- Q83301615 P478 Q83301615-9CE8F7F2-BD86-4D80-8314-8ADB505B48B6 @default.
- Q83301615 P577 Q83301615-F98DD2D1-9047-4630-BADA-56FF71876FB6 @default.
- Q83301615 P698 Q83301615-F88514DE-1703-4EBC-A4FA-05743C532362 @default.
- Q83301615 P921 Q83301615-BC2B0FDE-A33A-4152-9B2C-DC1E78BFF729 @default.
- Q83301615 P356 J.YMGME.2008.12.015 @default.
- Q83301615 P698 19195916 @default.
- Q83301615 P1433 Q6895949 @default.
- Q83301615 P1476 "A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1" @default.
- Q83301615 P2093 "A C Puga" @default.
- Q83301615 P2093 "A Mehta" @default.
- Q83301615 P2093 "G M Pastores" @default.
- Q83301615 P2093 "M DiRocco" @default.
- Q83301615 P2093 "N J Weinreb" @default.
- Q83301615 P2093 "P Kaplan" @default.
- Q83301615 P2093 "P S Kishnani" @default.
- Q83301615 P2093 "R M Lemay" @default.
- Q83301615 P2093 "S E Smith" @default.
- Q83301615 P2283 Q1231081 @default.
- Q83301615 P2860 Q33334590 @default.
- Q83301615 P2860 Q33365037 @default.
- Q83301615 P2860 Q33371432 @default.
- Q83301615 P2860 Q33374222 @default.
- Q83301615 P2860 Q34109918 @default.
- Q83301615 P2860 Q37176146 @default.
- Q83301615 P2860 Q50872092 @default.
- Q83301615 P2860 Q51902982 @default.
- Q83301615 P2860 Q53241550 @default.
- Q83301615 P2860 Q53542726 @default.
- Q83301615 P2860 Q74497670 @default.
- Q83301615 P2860 Q79219038 @default.
- Q83301615 P2860 Q81745405 @default.
- Q83301615 P304 "164-170" @default.
- Q83301615 P31 Q13442814 @default.
- Q83301615 P356 "10.1016/J.YMGME.2008.12.015" @default.
- Q83301615 P433 "4" @default.
- Q83301615 P478 "96" @default.
- Q83301615 P577 "2009-02-04T00:00:00Z" @default.
- Q83301615 P698 "19195916" @default.
- Q83301615 P921 Q861645 @default.